However, apoptotic or necrotic cell death independent of mitotic catastrophe in p53-deficient cells cannot be excluded as a contributor to the overall enhanced AML cell killing in response to the calicheamicin/M3814 combination. Here, TP53 is linked to acute myeloid leukemia.